GSK - GSK Plc - ADR
Close
43.91
0.170 0.387%
Share volume: 3,129,062
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$43.74
0.17
0.39%
Fundamental analysis
54%
Profitability
63%
Dept financing
49%
Liquidity
51%
Performance
48%
Performance
5 Days
3.00%
1 Month
11.45%
3 Months
0.69%
6 Months
5.55%
1 Year
28.42%
2 Year
43.82%
Key data
Stock price
$43.91
DAY RANGE
$43.53 - $43.98
52 WEEK RANGE
$32.44 - $45.37
52 WEEK CHANGE
$0.30
DIVIDEND
$0.3857
EX-DIVIDEND DATE
08/16/2024
NEXT EARNINGS DATE
10/30/2024
Company detail
CEO: Emma Walmsley
Region: US
Website: https://www.gsk.com/
Employees: 69,400
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.gsk.com/
Employees: 69,400
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England.
Recent news